Sponsor: University of Pennsylvania Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Follow-Up Study (CATT FS) Read More

Sponsor: Lpath, Inc. A Phase 2A, Multi-center, Masked, Randomized, Comparator-Controlled study evaluating iSONEP (Sonepcizumab [LT1009]) as either monotherapy to Lucentis, Avastin or Eylea ver Read More

Sponsor: Pan Optica A Phase 1 Open-Label, Multi-Center Trial with Randomization to Dose to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients with Neovascular Age-Rel Read More

Sponsor: Ophthotech A Phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous administration of Fovista (Anti PDGF-B Pegylated Aptamer) admini Read More

Sponsor: Genentech A phase IIIb, multicenter, randomized, controlled study of the safety, tolerability and efficacy of intravitreal injections of 0.5mg ranibizumab given monthly compared to a  Read More

An Open-Label Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection) in Patients with Neovascular Age-Related Macular  Read More